Every weight loss journey is unique, which is why we start with a personalized consultation to understand your specific needs, health history, and goals
The unique 3 ml multi-dose pen configuration offers absolute dosing flexibility, allowing users to dial and administer specific therapeutic increments ( 0.25 mg, 0.5 mg, or 1 mg per injection ) as required by their current baseline protocol
A 2002 review in Growth Hormone and IGF Research covering over 1,000 treated patients found no evidence of increased cancer risk, glucose intolerance, or antibody-mediated resistance with long-term use
Eating smaller meals, staying hydrated, and avoiding high-fat foods may help reduce gastrointestinal symptoms
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial